Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.

By H. Oettle, P. Neuhaus, Andreas Hochhaus, J. Hartmann, K. Gellert, K. Ridwelski, M. Niedergethmann, C. Zülke, J. Fahlke, M. Arning and 3 more. Journal of the American Medical Association (JAMA), 2013

1,750 citations recorded by the source corpus.

Subfields: Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/a5b1dbdcb81152657364875bc787e8f0ddb9a214

Citations in the corpus

• Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. (2021, neutral): “01).(128) An absolute survival difference of 10.”